LncRNA HEIH Confers Cell Sorafenib Resistance in Hepatocellular Carcinoma by Regulating miR-98-5p/PI3K/AKT Pathway

Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma

(2019) Michael Teufel et al.   GASTROENTEROLOGY

LncRNA SNHG1 contributes to sorafenib resistance by activating the Akt pathway and is positively regulated by miR-21 in hepatocellular carcinoma cells

(2019) Weidong Li et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

LncRNA FOXD2-AS1 as a competitive endogenous RNA against miR-150-5p reverses resistance to sorafenib in hepatocellular carcinoma

(2019) Chengjun Sui et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Silence of lncRNA HEIH suppressed liver cancer cell growth and metastasis through miR‐199a‐3p/mTOR axis

(2019) Yongbiao Ma et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Sorafenib inhibits proliferation and invasion in desmoid-derived cells by targeting Ras/MEK/ERK and PI3K/Akt/mTOR pathways

(2018) Laura Rosenberg et al.   CARCINOGENESIS

Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4

(2018) Yue Fu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

miR-98-5p contributes to cisplatin resistance in epithelial ovarian cancer by suppressing miR-152 biogenesis via targeting Dicer1

(2018) Yanan Wang et al.   Cell Death & Disease

Inhibition of the PI3K/Akt signaling pathway reverses sorafenib‑derived chemo‑resistance in hepatocellular carcinoma

(2018) Hao Zhang et al.   Oncology Letters

Long Noncoding RNA HEIH Promotes Colorectal Cancer Tumorigenesis via Counteracting miR-939‒Mediated Transcriptional Repression of Bcl-xL

(2018) Chunhui Cui et al.   Cancer Research and Treatment

Cabozantinib as a Second-Line Agent in Advanced Hepatocellular Carcinoma

(2018) Masatoshi Kudo   Liver Cancer

LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma

(2018) Peng-Fei Zhang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

(2017) Jordi Bruix et al.   LANCET

Upregulation of miR-137 reverses sorafenib resistance and cancer-initiating cell phenotypes by degrading ANT2 in hepatocellular carcinoma

(2017) Ai-Qing Lu et al.   ONCOLOGY REPORTS

MicroRNA-98-5p Inhibits Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma via Targeting IGF2BP1

(2017) Tinghui Jiang et al.   ONCOLOGY RESEARCH

Sorafenib: A Review in Hepatocellular Carcinoma

(2017) Gillian M. Keating   Targeted Oncology

Mechanisms of long noncoding RNA function in development and disease

(2016) Sandra U. Schmitz et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Exosomes derived from HCC cells induce sorafenib resistance in hepatocellular carcinoma both in vivo and in vitro

(2016) Zhen Qu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Long noncoding RNA-SRLR elicits intrinsic sorafenib resistance via evoking IL-6/STAT3 axis in renal cell carcinoma

(2016) Z Xu et al.   ONCOGENE

NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells

(2016) Pan Jiang et al.   Oncotarget

An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells

(2016) Shuyao Tang et al.   Oncotarget

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway

(2015) Changjun He et al.   Oncotarget

MicroRNAs in Cancer

(2013) Gianpiero Di Leva et al.   Annual Review of Pathology-Mechanisms of Disease

Potential roles of microRNAs in regulating long intergenic noncoding RNAs

(2013) Liran Juan et al.   BMC Medical Genomics

The hallmarks of cancer

(2012) Tony Gutschner et al.   RNA Biology